Advertisement

Topics

InVivo Therapeutics Announces New Patient Enrollment into The INSPIRE Study at Allegheny General Hospital

08:00 EDT 20 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
InVivo Therapeutics Holdings Corp. (NVIV) today announced that a new patient has been enrolled into The INSPIRE Study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold™ for Safety and Neurologic Recovery in Subje...

Other Sources for this Article

InVivo Therapeutics
Investor Relations
Heather Hamel, 617-863-5530
Investor-relations@invivotherapeutics.com

NEXT ARTICLE

More From BioPortfolio on "InVivo Therapeutics Announces New Patient Enrollment into The INSPIRE Study at Allegheny General Hospital"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Spinal Cord Disorders
The spinal cord is a bundle of nerves that runs down the middle of the back which carry signals back and forth between the body and brain. It is protected by vertebrae, which are the bone disks that make up the spine. An accident that damages the verte...